141 related articles for article (PubMed ID: 30477195)
1. The Myeloid-Epithelial-Reproductive Tyrosine Kinase (MERTK) rs4374383 Polymorphism Predicts Progression of Liver Fibrosis in Hepatitis C Virus-Infected Patients: A Longitudinal Study.
Jiménez-Sousa MÁ; Gómez-Moreno AZ; Pineda-Tenor D; Brochado-Kith O; Sánchez-Ruano JJ; Artaza-Varasa T; Gómez-Sanz A; Fernández-Rodríguez A; Resino S
J Clin Med; 2018 Nov; 7(12):. PubMed ID: 30477195
[TBL] [Abstract][Full Text] [Related]
2. CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study.
Jiménez-Sousa MÁ; Gómez-Moreno AZ; Pineda-Tenor D; Medrano LM; Sánchez-Ruano JJ; Fernández-Rodríguez A; Artaza-Varasa T; Saura-Montalban J; Vázquez-Morón S; Ryan P; Resino S
Clin Transl Med; 2017 Dec; 6(1):26. PubMed ID: 28755163
[TBL] [Abstract][Full Text] [Related]
3. PNPLA3 rs738409 polymorphism is associated with liver fibrosis progression in patients with chronic hepatitis C: A repeated measures study.
Jiménez-Sousa MÁ; Gómez-Moreno AZ; Pineda-Tenor D; Sánchez-Ruano JJ; Fernández-Rodríguez A; Artaza-Varasa T; Gómez-Sanz A; Martín-Vicente M; Vázquez-Morón S; Resino S
J Clin Virol; 2018 Jun; 103():71-74. PubMed ID: 29674183
[TBL] [Abstract][Full Text] [Related]
4. MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease.
Petta S; Valenti L; Marra F; Grimaudo S; Tripodo C; Bugianesi E; Cammà C; Cappon A; Di Marco V; Di Maira G; Dongiovanni P; Rametta R; Gulino A; Mozzi E; Orlando E; Maggioni M; Pipitone RM; Fargion S; Craxì A
J Hepatol; 2016 Mar; 64(3):682-90. PubMed ID: 26596542
[TBL] [Abstract][Full Text] [Related]
5. IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection.
Jiménez-Sousa MA; Berenguer J; Rallón N; Pineda-Tenor D; Aldamiz-Echevarria T; Soriano V; García-Álvarez M; Vazquez-Morón S; Restrepo C; Carrero A; Benito JM; Resino S
Liver Int; 2016 Sep; 36(9):1258-66. PubMed ID: 26836972
[TBL] [Abstract][Full Text] [Related]
6. TRPM5 rs886277 Polymorphism Predicts Hepatic Fibrosis Progression in Non-Cirrhotic HCV-Infected Patients.
Resino S; Fernández-Rodríguez A; Pineda-Tenor D; Gómez-Moreno AZ; Sánchez-Ruano JJ; Artaza-Varasa T; Muñoz-Gómez MJ; Virseda-Berdices A; Martín-Vicente M; Martínez I; Jiménez-Sousa MA
J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33525598
[TBL] [Abstract][Full Text] [Related]
7. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.
Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M
HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826
[TBL] [Abstract][Full Text] [Related]
8. MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat.
Musso G; Cassader M; De Michieli F; Paschetta E; Pinach S; Saba F; Bongiovanni D; Framarin L; Berrutti M; Leone N; Corvisieri S; Parente R; Molinaro F; Sircana A; Bo S; Gambino R
Hum Mol Genet; 2017 May; 26(9):1747-1758. PubMed ID: 28334911
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive Assessment of Liver Fibrosis By Transient Elastography and FIB4/APRI for Prediction of Treatment Response in Chronic Hepatitis C-An Experience from a Tertiary Care Hospital.
Taneja S; Tohra S; Duseja A; Dhiman RK; Chawla YK
J Clin Exp Hepatol; 2016 Dec; 6(4):282-290. PubMed ID: 28003717
[TBL] [Abstract][Full Text] [Related]
10. Impact of
Jiménez-Sousa MÁ; Gómez-Moreno AZ; Pineda-Tenor D; Sánchez-Ruano JJ; Artaza-Varasa T; Martin-Vicente M; Fernández-Rodríguez A; Martínez I; Resino S
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 30970632
[No Abstract] [Full Text] [Related]
11. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
Barreiro P; Pineda JA; Rallón N; Naggie S; Martín-Carbonero L; Neukam K; Rivero A; Benito JM; Caruz A; Vispo E; Camacho A; Medrano J; McHutchison J; Soriano V
J Infect Dis; 2011 Jun; 203(11):1629-36. PubMed ID: 21592993
[TBL] [Abstract][Full Text] [Related]
12. Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience.
Dolmazashvili E; Abutidze A; Chkhartishvili N; Karchava M; Sharvadze L; Tsertsvadze T
Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1223-1230. PubMed ID: 28857900
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.
Patin E; Kutalik Z; Guergnon J; Bibert S; Nalpas B; Jouanguy E; Munteanu M; Bousquet L; Argiro L; Halfon P; Boland A; Müllhaupt B; Semela D; Dufour JF; Heim MH; Moradpour D; Cerny A; Malinverni R; Hirsch H; Martinetti G; Suppiah V; Stewart G; Booth DR; George J; Casanova JL; Bréchot C; Rice CM; Talal AH; Jacobson IM; Bourlière M; Theodorou I; Poynard T; Negro F; Pol S; Bochud PY; Abel L; ;
Gastroenterology; 2012 Nov; 143(5):1244-1252.e12. PubMed ID: 22841784
[TBL] [Abstract][Full Text] [Related]
14. Outreach screening of drug users for cirrhosis with transient elastography.
Moessner BK; Jørgensen TR; Skamling M; Vyberg M; Junker P; Pedersen C; Christensen PB
Addiction; 2011 May; 106(5):970-6. PubMed ID: 21182552
[TBL] [Abstract][Full Text] [Related]
15. PNPLA3 and RNF7 Gene Variants are Associated with the Risk of Developing Liver Fibrosis and Cirrhosis in an Eastern European Population.
Kupcinskas J; Valantiene I; Varkalaitė G; Steponaitiene R; Skieceviciene J; Sumskiene J; Petrenkiene V; Kondrackiene J; Kiudelis G; Lammert F; Kupcinskas L
J Gastrointestin Liver Dis; 2017 Mar; 26(1):37-43. PubMed ID: 28338112
[TBL] [Abstract][Full Text] [Related]
16.
Pineda-Tenor D; Gómez-Moreno AZ; Sánchez-Ruano JJ; Artaza-Varasa T; Virseda-Berdices A; Fernández-Rodríguez A; Mendoza PM; Jiménez-Sousa MÁ; Resino S
Front Med (Lausanne); 2020; 7():582666. PubMed ID: 33304912
[No Abstract] [Full Text] [Related]
17. Dysregulation of the Immune System in HIV/HCV-Coinfected Patients According to Liver Stiffness Status.
Garcia-Broncano P; Medrano LM; Berenguer J; González-García J; Jiménez-Sousa MÁ; Carrero A; Hontañón V; Guardiola JM; Crespo M; Quereda C; Sanz J; García-Gómez AB; Jimenez JL; Resino S;
Cells; 2018 Nov; 7(11):. PubMed ID: 30400258
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response.
D'Ambrosio R; Aghemo A; Fraquelli M; Rumi MG; Donato MF; Paradis V; Bedossa P; Colombo M
J Hepatol; 2013 Aug; 59(2):251-6. PubMed ID: 23528378
[TBL] [Abstract][Full Text] [Related]
19. Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.
Macías J; Mancebo M; Márquez M; Merino D; Téllez F; Rivero A; von Wichmann MA; López-Cortés LF; Merchante N; Santos J; Raffo M; Pérez-Pérez M; Camacho Á; Iribarren JA; Pineda JA
Hepatology; 2015 May; 61(5):1503-11. PubMed ID: 25545020
[TBL] [Abstract][Full Text] [Related]
20. Liver stiffness measurement predicts liver-related events in patients with chronic hepatitis C: A retrospective study.
Gomez-Moreno AZ; Pineda-Tenor D; Jimenez-Sousa MA; Sánchez-Ruano JJ; Artaza-Varasa T; Saura-Montalban J; Ryan P; Resino S
PLoS One; 2017; 12(9):e0184404. PubMed ID: 28880930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
